Silk Road Medical (SILK)
(Delayed Data from NSDQ)
$17.67 USD
+0.64 (3.76%)
Updated Apr 23, 2024 04:00 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Silk Road Medical (SILK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$16.75 | $25.00 | $8.00 | -5.21% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Silk Road Medical comes to $16.75. The forecasts range from a low of $8.00 to a high of $25.00. The average price target represents a decline of 5.21% from the last closing price of $17.67.
Analyst Price Targets (8 )
Broker Rating
Silk Road Medical currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 2.50 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, four are Strong Buy, representing 40% of all recommendations. A month ago, Strong Buy represented 40%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.50 | 2.50 | 2.50 | 2.70 | 2.70 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/6/2024 | Argus Research Corp. | Steve Silver | Hold | Strong Buy |
2/29/2024 | Piper Sandler | Adam C Maeder | Hold | Hold |
1/3/2024 | Lake Street Capital Markets | Frank Takkinen | Not Available | Strong Buy |
10/11/2023 | C.L. King & Associates | Kristen M Stewart | Moderate Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 10 |
Average Target Price | $16.75 |
LT Growth Rate | 6.10% |
Industry | Medical - Instruments |
Industry Rank by ABR | 95 of 252 |
Current Quarter EPS Est: | -0.40 |